Scientists test if vaccine can disarm active HPV virus

NCT ID NCT07407569

Summary

This study is exploring whether giving the Gardasil-9 vaccine to women who already have an HPV16 infection can reduce the virus's ability to spread. About 50 women with HPV16 but no visible symptoms will receive two vaccine doses. Researchers will track changes in the virus and the women's immune responses using urine and blood samples over two years to learn more about how the vaccine works in this situation.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS INFECTION TYPE 16 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antwerp University Hospital

    RECRUITING

    Antwerp, Wilrijk, 2650, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospital Ghent

    RECRUITING

    Ghent, 9000, Belgium

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospital Leuven

    RECRUITING

    Leuven, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.